ABIRATERONE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 266 adverse event reports in the FDA FAERS database where ABIRATERONE was used for Neoplasm malignant.
Most Reported Side Effects for ABIRATERONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 5,623 | 16.3% | 5,571 | 308 |
| Fatigue | 1,928 | 5.6% | 77 | 299 |
| Drug ineffective | 1,732 | 5.0% | 106 | 145 |
| Therapy cessation | 1,602 | 4.6% | 17 | 123 |
| Prostatic specific antigen increased | 1,581 | 4.6% | 96 | 182 |
| Disease progression | 1,098 | 3.2% | 122 | 76 |
| Hospitalisation | 1,034 | 3.0% | 99 | 983 |
| Hot flush | 989 | 2.9% | 14 | 86 |
| Asthenia | 891 | 2.6% | 79 | 333 |
| Off label use | 859 | 2.5% | 100 | 231 |
| Fall | 804 | 2.3% | 67 | 476 |
| Nausea | 735 | 2.1% | 62 | 196 |
| Diarrhoea | 731 | 2.1% | 57 | 204 |
| Hypertension | 687 | 2.0% | 43 | 200 |
| Prostate cancer | 661 | 1.9% | 267 | 163 |
Other Indications for ABIRATERONE
Product used for unknown indication (12,433)
Prostate cancer (12,209)
Prostate cancer metastatic (3,535)
Hormone-refractory prostate cancer (1,378)
Hormone-dependent prostate cancer (236)
Metastases to bone (147)
Prostate cancer stage iv (94)
Bone cancer (67)
Neoplasm prostate (50)
Metastasis (40)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)